If Moderna Is 'Executing Superbly' On Its COVID-19 Vaccine Portfolio, Why Is This Analyst Downgrading The Stock?
Inovio Shares Rally As Oppenheimer Says Coronavirus Vaccine Developer Approaching Finish Line
If Moderna Is 'Executing Superbly' On Its COVID-19 Vaccine Portfolio, Why Is This Analyst Downgrading The Stock?
Inovio Shares Rally As Oppenheimer Says Coronavirus Vaccine Developer Approaching Finish Line
Moderna Will Start To Outrun Coronavirus Competition In 2021, Analyst Says
Moderna Analyst Says Biotech Has 'First-To-Market' Potential For Coronavirus Vaccine
Hartaj Singh Recent News
Down 16% Over May, Has Sarepta Become A Cheap Takeout Target?
Here's Why Sarepta Therapeutics May Be The Rarest Of Finds: A 'Value' Biotech Stock
Oppenheimer Stays Bullish On Sarepta As Concerns Continue To Swirl
Decreasing Visibility: BTIG Downgrades EPRS To Neutral
SunTrust: Medivation M&A Chatter Highlights Value, Company's 'Unique' Industry Position
BTIG: Medivation Acquirer Could Pay 20-30% Premium And Still Buy At Low Valuation
UPDATE: BTIG Initiates Coverage On Alexion Pharmaceuticals
UPDATE: BTIG Initiates Coverage On Pharmacyclics
BTIG Initiates Coverage On Sunesis Pharmaceuticals, Believes Company 'Will Be Breakeven By 2017'
UPDATE: BTIG Initiates Coverage On United Therapeutics
BTIG Initiates Coverage On Vertex Pharmaceuticals, Notes Company's Cystic Fibrosis Therapies